Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Surgical Snares Market Size & Share 2026-2035
Report ID: GMI5641
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Surgical Snares Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Surgical Snares Market Size
The surgical snares market was valued at USD 1.40 billion in 2025, is expected to reach USD 1.52 billion in 2026, and is projected to expand at a 7.4% CAGR (2026-2035), reaching USD 2.90 billion by 2035.
Surgical Snares Market Key Takeaways
Market Leader: Olympus Corporation led with over 22% market share in 2025.
Leading Players: Top 5 players in this market include Olympus Corporation, Boston Scientific Corporation, Cook Medical, Medtronic plc, CONMED Corporation, which collectively held a market share of 69% in 2025.
The surgical snares market is being reshaped by the convergence of rising endoscopic procedure volumes, infection-control priorities, and the migration of routine interventions toward outpatient settings. Demand increasingly favors sterile, procedure-ready devices that reduce reprocessing requirements while enabling clinicians to address differing lesion characteristics across gastrointestinal and adjacent minimally invasive procedures.
GMI Analyst View
Based on primary input from hospital endoscopy program directors and outpatient procedure administrators engaged through our pre-launch research process, the surgical snares market generated approximately USD 1.30 billion in revenue in 2024. We view that trajectory as evidence of an established procedural demand base entering the forecast period, with ambulatory adoption and organized screening capacity reinforcing the market's underlying resilience.
Surgical Snares Market Trends, Growth Drivers & GMI Forecast Outlook
Procedure growth alone will not determine market performance. The outlook depends on where interventions are performed, which resection techniques clinicians select, and whether suppliers can align sterile single-use portfolios with the purchasing discipline of increasingly consolidated ambulatory and hospital systems.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Ambulatory migration changes both the volume and character of device purchasing. Facilities operating high-throughput endoscopy lists favor workflow reliability, standardized procedure kits, and reduced instrument-turnaround burden. That operating model supports disposable snare adoption, particularly where a facility's purchasing team can align clinical preferences with standardized supply agreements across multiple procedure rooms.
Screening expansion provides the upstream procedural base for this shift. Colorectal cancer screening prevalence among U.S. adults aged 45 and older increased to 65% in 2023 from 59% in 2021, while federally qualified health centers screened 3,617,246 patients in 2024 [3]American Cancer Society National Colorectal Cancer Roundtable. "Data and Progress." nccrt.org. As more patients enter surveillance and diagnostic pathways, lesion-removal encounters become a recurring source of snare demand rather than a one-time screening effect.
Technique guidance is also directing product development. ESGE's recommendation for cold snare use in diminutive and small polyps has increased the commercial value of wire geometry, loop stability, and cutting performance without electrosurgical activation [4]European Society of Gastrointestinal Endoscopy. "Colorectal Polypectomy and Endoscopic Mucosal Resection: ESGE Guideline Update 2024." esge.com. Suppliers that can offer a clinically intuitive range of cold, hot, and hybrid designs are better placed to capture procedure-room standardization decisions without forcing clinicians to compromise on lesion-specific technique.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Technique variability limits the extent to which procedure growth converts directly into snare consumption. In smaller-lesion cases, continued forceps use can bypass the snare category altogether, especially where clinician training, established habits, or local practice patterns have not fully aligned with contemporary guideline preferences. The result is a lower attachment rate per endoscopic procedure than headline procedure volumes alone might suggest.
Complex-lesion management creates a separate constraint. Large or technically demanding resections often require electrosurgical control, deeper tissue management, or additional accessory support that a conventional cold snare cannot replace. Manufacturers therefore face a portfolio challenge: they must advance cold-snare usability while preserving hot-snare and resection-system capabilities for higher-acuity cases.
Procurement concentration further narrows the path to share gains. Group purchasing agreements and hospital-system standardization can reward broad portfolios, dependable supply, and demonstrated clinician familiarity, making it difficult for a single-category entrant to displace established suppliers even when its device offers a differentiated feature set.
GMI Analyst View
We expect the market's central tension to remain between outpatient procedure efficiency and the clinical complexity of lesion management. Suppliers that combine reliable disposable formats with credible options for advanced resection are likely to defend pricing and account access more effectively than companies competing on unit cost alone.
Surgical Snares Market Segment Analysis
By Product Type
Within the surgical snares market, single-use snares generated USD 910 million in revenue in 2025 and are projected to account for 70.0% of market revenue by 2035. Their adoption reflects the operational value of sterile, ready-to-use instruments in high-throughput endoscopy environments, where avoiding reprocessing steps can simplify room turnover, documentation, and inventory control. Product differentiation is increasingly centered on loop geometry, wire stiffness, handle control, and compatibility with varied working-channel requirements.
Reusable surgical snares accounted for 35.0% of market revenue in 2025 and are projected to generate USD 870 million by 2035. The category remains relevant where hospitals have established reprocessing infrastructure and procurement decisions prioritize lower per-unit acquisition costs. Its competitive position depends on validated cleaning protocols, durability, and supplier relationships that can support tenders in cost-sensitive healthcare systems.
By Application
GI endoscopy accounted for 65.0% of market revenue in 2025 and is projected to reach USD 1.83 billion by 2035. The surgical snares market remains anchored in GI endoscopy because colonoscopy and related procedures provide the most consistent global volume of polypectomy and tissue-resection encounters. Clinical preference for lesion-specific resection tools also makes GI practice the principal setting for innovation in cold, hot, and hybrid snare designs.
Urology endoscopy represented 12.0% of market revenue in 2025 and is projected to reach USD 377 million by 2035. Snare use in ureteroscopy and cystoscopy is supported by recurring requirements for retrieval and lesion-management procedures. The segment offers suppliers an opportunity to reduce reliance on GI demand by adapting device configurations to specialty-specific access, retrieval, and visualization needs.
Laparoscopy accounted for 8.0% of market revenue in 2025 and is projected to expand at an 8.7% CAGR (2026-2035). Its demand is linked to broader use of minimally invasive approaches in general surgery and other abdominal procedures. Commercial success in this application depends on device reliability through ports, intuitive control during tissue handling, and integration into procedure-specific accessory portfolios.
Gynecology endoscopy accounted for 6.0% of market revenue in 2025 and is projected to reach USD 174 million by 2035. Hysteroscopic interventions create demand for controlled lesion removal in settings where fertility preservation and outpatient treatment are increasingly important. Suppliers must balance precision and ease of use with the purchasing requirements of office-based and ambulatory gynecological practices.
Bronchoscopy generated USD 56 million in revenue in 2025 and is projected to reach USD 116 million by 2035. Growth is supported by expanding interventional pulmonology capabilities, including retrieval and lesion-management procedures. This remains a specialized application in which device maneuverability and compatibility with flexible bronchoscopic workflows are critical to adoption.
By End-User
Hospitals & clinics generated USD 840 million in revenue in 2025 and are projected to account for 55.0% of market revenue by 2035. These settings retain a central role because they manage a wide acuity range, from complex polypectomy and advanced resection to emergency retrieval procedures. Their purchasing decisions place weight on clinical breadth, supply continuity, and compatibility with established endoscopy infrastructure.
Ambulatory surgical centers accounted for 35.0% of market revenue in 2025 and are projected to reach USD 1.19 billion by 2035. Their growth reflects the movement of routine endoscopic procedures into lower-cost care settings with structured scheduling and standardized supply pathways. ASC demand favors suppliers that can support efficient kit-based procurement, dependable disposable inventory, and contracting models aligned with procedure throughput.
GMI Analyst View
We see the most consequential segment shift occurring where disposable product design, GI procedure volume, and ambulatory purchasing intersect. Incumbents with broad portfolios retain advantages in complex care settings, while focused innovators can create defensible positions by solving workflow and performance needs within high-volume outpatient procedures.
Surgical Snares Market Regional Analysis
North America Surgical Snares Market Analysis
North America generated USD 532 million in revenue in 2025 and is projected to reach USD 1.04 billion by 2035. The surgical snares market in North America benefits from mature endoscopy capacity, a developed ASC ecosystem, and procurement practices that increasingly reward procedure-ready disposable devices. Screening pathways and outpatient reimbursement structures provide a durable procedural foundation, while sophisticated hospital accounts sustain demand for advanced resection options.
U.S.
The U.S. generated USD 490 million in revenue in 2025 and is projected to account for 33.0% of global market revenue by 2035. It combines high endoscopy utilization with a broad ambulatory delivery network, making it the region's most commercially significant country market. Snare-based lesion removal rose in the ASC Medicare procedure ranking between 2019 and 2024, underscoring the importance of outpatient access and standardized purchasing in shaping supplier demand [1]Medicare Payment Advisory Commission. "Ambulatory Surgical Center Services: Status Report." medpac.gov.
Canada
Canada accounted for 3.0% of global market revenue in 2025 and is projected to expand at a 7.3% CAGR (2026-2035). Provincial procurement structures favor longer contracting cycles and evidence-supported product selection. Organized screening programs and capacity investments support steady demand, while the pace of disposable adoption varies with provincial budget priorities and reprocessing capabilities.
Europe Surgical Snares Market Analysis
Europe accounted for 26.0% of market revenue in 2025 and is projected to reach USD 667 million by 2035. Established national screening programs and high clinical standards support a stable demand base, although the transition toward single-use devices remains uneven across healthcare systems. Tendering frameworks, reimbursement structures, and sustainability priorities will influence product mix more strongly than procedure growth alone.
Germany
Germany generated USD 98 million in revenue in 2025 and is projected to expand at a 5.6% CAGR (2026-2035). Its mature endoscopy infrastructure and structured quality expectations support recurring demand for established accessory platforms. Growth is moderated by the country's developed screening baseline and procurement environment, which places a premium on clinical validation and value-based purchasing.
UK
The UK accounted for 5.0% of global market revenue in 2025 and is projected to reach USD 120 million by 2035. Bowel screening pathways provide a relatively predictable source of colonoscopy follow-up activity. Framework purchasing can favor suppliers able to demonstrate both cost discipline and continuity across single-use and reusable product lines.
France
France accounted for 5.0% of global market revenue in 2025 and is projected to reach USD 127 million by 2035. National screening and follow-up pathways provide an underlying procedure base, while adoption is shaped by the differing purchasing practices of public hospitals and private gastroenterology providers. Suppliers with localized commercial coverage and tender expertise are positioned to address this fragmented demand environment.
Asia Pacific Surgical Snares Market Analysis
Asia Pacific accounted for 24.0% of market revenue in 2025 and is projected to expand at an 8.9% CAGR (2026-2035). The region's growth is driven by expanding endoscopy infrastructure, rising diagnostic activity, and greater investment in minimally invasive care. Its opportunity is not uniform: advanced markets require differentiated technology and quality assurance, while emerging markets require distribution reach, clinical training, and price-sensitive portfolio design.
China
China generated USD 126 million in revenue in 2025 and is projected to expand at a 10.1% CAGR (2026-2035). Expanding endoscopy access and increasing institutional investment in GI care are strengthening demand for both established and localized device offerings. Boston Scientific's acquisition of Anrei Medical signals continued interest in building locally relevant GI-device capabilities within the country's expanding endotherapy market [7]Boston Scientific Corporation. "Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2025." sec.gov.
Japan
Japan accounted for 6.0% of global market revenue in 2025 and is projected to reach USD 148 million by 2035. Its sophisticated endoscopy ecosystem and high clinical standards support demand for devices that provide precise control and consistent performance. Domestic and international suppliers must compete on technical credibility, physician familiarity, and compatibility with advanced therapeutic workflows.
India
India accounted for 4.0% of global market revenue in 2025 and is projected to expand at an 11.0% CAGR (2026-2035). Private hospital growth, expanding endoscopy capacity, and increasing access to formal healthcare services are widening the procedural base. The market offers a meaningful long-term conversion opportunity for single-use formats, although price sensitivity and distributor effectiveness will remain decisive commercial factors.
Latin America Surgical Snares Market Analysis
Latin America accounted for 6.0% of market revenue in 2025 and is projected to reach USD 203 million by 2035. Demand is supported by private-provider investment and growing awareness of colorectal screening, but resource constraints continue to influence the speed of disposable-device penetration. Suppliers must calibrate product positioning to varied reimbursement conditions and public-private care mixes.
Brazil
Brazil generated USD 42 million in revenue in 2025 and is projected to expand at an 8.8% CAGR (2026-2035). Private healthcare networks and major urban endoscopy centers provide the strongest near-term commercial base. Broader growth will depend on how effectively screening awareness and procedural access extend beyond concentrated metropolitan settings.
Mexico
Mexico accounted for 2.0% of global market revenue in 2025 and is projected to reach USD 68 million by 2035. Growth is linked to the development of private hospital capacity and ambulatory services in major cities. Accessible single-use configurations and reliable local distribution are likely to be more commercially important than premium feature differentiation alone.
Middle East & Africa Surgical Snares Market Analysis
Middle East & Africa accounted for 6.0% of market revenue in 2025 and is projected to expand at a 9.2% CAGR (2026-2035). Healthcare modernization programs in Gulf markets and selective investments in endoscopy access elsewhere in the region are broadening demand. Market development remains dependent on hospital capital investment, clinical training, and procurement access rather than on a single common regional pathway.
Saudi Arabia
Saudi Arabia accounted for 1.5% of global market revenue in 2025 and is projected to expand at a 10.1% CAGR (2026-2035). Hospital investment and modernization of specialty-care capacity are increasing access to endoscopic services. International suppliers that can meet institutional qualification requirements and support local distribution are well placed to participate in the country's expanding procurement base.
UAE
The UAE accounted for 1.0% of global market revenue in 2025 and is projected to reach USD 38 million by 2035. Concentrated hospital networks, private care delivery, and medical-tourism activity support demand for internationally recognized device configurations. Commercial success depends on timely regulatory access, account coverage, and the ability to serve high-expectation clinical environments.
GMI Analyst View
We view North America as the market's principal commercial anchor because its outpatient infrastructure combines procedural scale with established purchasing pathways. Asia Pacific offers the clearest expansion opportunity, but winning there will require localized distribution, clinical education, and portfolio segmentation rather than a simple replication of Western market strategies.
Surgical Snares Market Share & Competitive Landscape
The surgical snares market share structure is moderately concentrated, with the top five companies collectively holding approximately 69% of global revenue in 2025. Competitive advantage rests on portfolio breadth, direct access to hospital and ASC accounts, clinical familiarity, and the ability to participate in contracting arrangements that increasingly govern institutional device purchasing.
Olympus Corporation held a 22% market share in 2025. Its integrated endoscopy platform gives the company a natural route to cross-sell therapeutic accessories within established capital-equipment relationships. Olympus is positioned to compete through procedural familiarity, broad compatibility across endoscopy workflows, and the ability to connect snare selection with a wider therapeutic-device ecosystem.
Boston Scientific Corporation held a 20% market share in 2025. The company's broad endoscopy portfolio allows it to address snare resection alongside hemostasis, biliary intervention, and other adjacent needs. This breadth is particularly valuable to hospital and ASC accounts seeking fewer suppliers, coordinated training, and standardized product availability across procedure rooms.
Cook Medical (Cook Group) held a 14% market share in 2025. Its competitive position is supported by a longstanding presence across GI and related endoscopic specialties, as well as distribution relationships that provide recurring access to procedural accounts. The company's ability to serve multiple clinical applications reduces dependence on any single resection workflow.
Medtronic plc and CONMED Corporation compete through broader GI and surgical portfolios, with differentiated relevance in accounts seeking consolidated sourcing and disposable-device options. Regional and emerging suppliers, including Micro-Tech Endoscopy, L&K Biomed Co. Ltd., Endo-Flex GmbH, Hobbs Medical Inc., US Endoscopy, Ovesco Endoscopy AG, Fujifilm Medical Systems USA, Merit Medical Systems, Medi-Globe GmbH, and Cantel Medical, add competitive pressure through specialty offerings, regional channels, and targeted price-performance positioning.
Recent Industry Developments
July 2025 - Boston Scientific completed the acquisition of Anrei Medical. Boston Scientific completed its acquisition of Anrei Medical (HZ) Co., Ltd. on July 11, 2025. Anrei Medical specializes in instruments for minimally invasive GI procedures, and the transaction expands Boston Scientific's localized endoscopy capabilities in China and the broader Asia Pacific region [7]Boston Scientific Corporation. "Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2025." sec.gov. The acquisition demonstrates how leading suppliers are using portfolio expansion and regional manufacturing relevance to strengthen their position in high-growth endotherapy markets.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →